134 related articles for article (PubMed ID: 36580420)
1. Methylphenidate improves cognitive function and health-related quality of life in survivors of childhood brain tumours.
Verity SJ; Halliday G; Hill RM; Ryles J; Bailey S
Neuropsychol Rehabil; 2024 Jan; 34(1):133-153. PubMed ID: 36580420
[TBL] [Abstract][Full Text] [Related]
2. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
4. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder.
Konrad K; Gunther T; Hanisch C; Herpertz-Dahlmann B
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):191-8. PubMed ID: 14726726
[TBL] [Abstract][Full Text] [Related]
6. Translating methylphenidate's efficacy on selective and sustained attentional deficits to those reported in childhood cancer survivors: A qualitative review.
Hagan AJ; Verity SJ
Appl Neuropsychol Child; 2023; 12(1):74-87. PubMed ID: 35108133
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
[TBL] [Abstract][Full Text] [Related]
8. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
[TBL] [Abstract][Full Text] [Related]
9. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.
Blum NJ; Jawad AF; Clarke AT; Power TJ
Dev Med Child Neurol; 2011 Sep; 53(9):843-849. PubMed ID: 21585365
[TBL] [Abstract][Full Text] [Related]
10. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
Nielsen NP; Wiig EH; Bäck S; Gustafsson J
Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
[TBL] [Abstract][Full Text] [Related]
11. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
[TBL] [Abstract][Full Text] [Related]
13. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder.
Wu CS; Shang CY; Lin HY; Gau SS
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):187-196. PubMed ID: 33890819
[No Abstract] [Full Text] [Related]
14. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity.
Mehta MA; Goodyer IM; Sahakian BJ
J Child Psychol Psychiatry; 2004 Feb; 45(2):293-305. PubMed ID: 14982243
[TBL] [Abstract][Full Text] [Related]
16. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
[TBL] [Abstract][Full Text] [Related]
17. Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder.
Hood J; Baird G; Rankin PM; Isaacs E
Dev Med Child Neurol; 2005 Jun; 47(6):408-14. PubMed ID: 15934489
[TBL] [Abstract][Full Text] [Related]
18. Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer.
Netson KL; Conklin HM; Ashford JM; Kahalley LS; Wu S; Xiong X
J Pediatr Psychol; 2011 May; 36(4):438-50. PubMed ID: 21097489
[TBL] [Abstract][Full Text] [Related]
19. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.
Low AM; Vangkilde S; le Sommer J; Fagerlund B; Glenthøj B; Jepsen JRM; Bundesen C; Petersen A; Habekost T
Psychol Med; 2019 Nov; 49(15):2617-2625. PubMed ID: 30560740
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
